Federal Court Rules Against Three Drug Companies in Average Wholesale Price Case

A major victory occurred today in the massive Average Wholesale Price lawsuit in the U.S. District Court for the District of Massachusetts. PAL's press release on this is below. To learn more about this case, go here. FOR IMMEDIATE RELEASE June 21, 2007

House Subcommittee caves in to Big Pharma on FDA Preemption provision

FDANews Drug Daily Bulletin reported today: The House Subcommittee on Health passed legislation renewing the Prescription Drug User Fee Act (PDUFA) and other provisions with few amendments after staff meetings resolved concerns including language elimina

"The Hill" gets it (partially) wrong on FDA & Preemption

"The Hill" today ran an article on June 15, titled "Trial lawyers’ win on suit provision threatens FDA bill." The article discusses a provision added to several discussion drafts of an unidentified FDA bill (presumably Prescription Drug User Fee Act [PDU

Judge approves amended First Databank settlement in case brought by PAL members

n June 2005 and February 2006, members of the PAL coalition AFSCME District Council 37 Health & Security Plan and New England Carpenters Health Benefits Fund filed lawsuits alleging that First Databank and McKesson carried out an illegal scheme from 2002

Community Catalyst & Robert Wood Johnson Foundation Announce $12M Effort to Support Consumer Advocacy for Health Care Coverage

Prescription Access Litigation's parent organization, Community Catalyst, today announced "Consumer Voices for Coverage," a major new initiative to support state health care advocacy in certain states. The program was launched today with a Call for Propo

State AG settlement on Ovcon reverse payment case shows need for further reform

The Attorneys General of 34 states and DC announced on Tuesday a $5.5 million settlement with Warner Chilcott. The settlement addresses the AGs' claims that Warner paid Barr laboratories $20 Million to not bring a generic version of the contraceptive Ovco

Bitter Pill Award winner Lunesta has most recalled drug ad

One of last year's Bitter Pill Awards honorees, Lunesta, has the dubious distinction of having the most recalled and most remembered drug ads on TV, according to IAG Research. In 2006, we gave Lunesta and Ambien our "While You Were Sleeping Award: For Ov

NPR's Marketplace features PAL Director discussing GSK's alli

NPR's Marketplace morning featured two stories today on the launch of GSK's over-the-counter weight loss drug alli. One of these stories featured Prescription Access Litigation director Alex Sugerman-Brozan discussing alli and why it should not be availab

NY Daily News dishes on Alli, highlights PAL's "With Allies Like this, Who Needs Enemas?" Award

Today's New York Daily News features a great article on the promise and pitfalls of GlaxoSmithKline's over-the-counter weight loss drug, Alli, ("Don't Swallow the Hype," by Julian Kesner) which is due to launch on Friday. Of course, we like the article
< 2 3 4 5 6 7 8